Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	35	non-cytoplasmic
36	58	transmembrane
59	89	cytoplasmic
90	113	transmembrane
114	119	non-cytoplasmic
120	140	transmembrane
141	149	cytoplasmic
150	170	transmembrane
171	188	non-cytoplasmic
189	209	transmembrane
210	221	cytoplasmic
222	247	transmembrane
248	266	non-cytoplasmic
267	291	transmembrane
292	318	cytoplasmic
319	339	transmembrane
340	350	non-cytoplasmic
351	371	transmembrane
372	382	cytoplasmic
383	402	transmembrane
403	407	non-cytoplasmic
408	426	transmembrane
427	461	cytoplasmic

Input:
>PfGW456L13_3775
MSVAKKMSVGQLTMLTAVNMLGSGIVLLPTKLAEVGAISILSWLITATGSLALAYAFARC
GMLSRKTGGMGGYAEYTFGKAGNYITNYTYGLSLLIANVAISITAVGYIQVLFGIELDSL
QVGLATIALLWITTFANFGGASITGRIGAVTVWGVIAPVVLVSTVGWFWFDSSVYAAGWN
PHDKGWFEAAGASVAITLWAFLGLESACANTDAVENPERNVPIAVLGGTLGAAVIYIVST
NVIFGIVGNEELAASTAPFGLVFAKMFTPMVGDIVMAAMVLACIGSLLGWQFTIAQVYKS
SADTGYFLPIFAKGNKAGTPIVGMLVLLAAQTALALLTISPDLSKQFDTLVNLAVVTNLV
PYILSMAALMTMQKVSNVPEGKALATNVIALIAAAYSYLALYSSGEQALMLGGVATIVGY
TLFGFVNNRLIRLEALNNSVPTQTVSAQHLTAEPVPVNNLN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server